Not a fan of IDX, infact seems pretty overvalued vs CAJ even after todays respective share price adjustment.
IDX carries pretty heavy debt and trades at a much loftier EV/EBITDA than CAJ. IDX has had a decent run from around $1.70 upto the $2.50 range even after some pretty average half year results, effectively diluting CAJ shareholders slice of the pie of the merger.
Not a great deal for CAJ holders, Sold 650k CAJ shares at open this morning which represented about half my holding.
Will probably keep the other half, still pretty bullish on healthcare/aging population/people getting unhealthier thematic.
Good luck all.
Ann: AGM - Chair's Address & Managing Director/CEO's Presentation, page-53
Add CAJ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.5¢ |
Change
-0.005(1.67%) |
Mkt cap ! $314.4M | |||
| Open | High | Low | Value | Volume |
| 30.0¢ | 30.0¢ | 29.5¢ | $552.2K | 1.859M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 284863 | 29.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.0¢ | 917476 | 10 |
View Market Depth
| Last trade - 16.10pm 15/08/2024 (20 minute delay) ? |
| CAJ (ASX) Chart |